BL Pharmtech equity acquisition/disposal: Gwangdong Health Bio
BL Pharmtech filed an equity acquisitions and disposals report on Nov 5, 2026. The target company named in the filing is Gwangdong Health Bio Co., Ltd.
Key facts
| Target company | Gwangdong Health Bio Co., Ltd. |
|---|
Comparison
| Revenue 2025 | ₩6.5bn |
|---|---|
| Revenue 2024 | ₩8.8bn |
| Revenue 2023 | ₩24.5bn |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗